Johannes-Gutenberg Universitaet Mainz
Mainz 55131
0 studies enrolling now · 13 studies all time
What they study most
Acute Myeloid Leukemia, Atherosclerotic Cardiovascular Disease, Atopic Dermatitis, Chronic Hepatitis C, Chronic Spontaneous Urticaria, Coronary Heart Disease (CHD), Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Heart Failure, Parkinson's Disease, Pulmonary Embolism, Relapsed or Refractory Multiple Myeloma
Studies at this site
- Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry — Recruiting now
- Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer. — Stopped early
- Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism — Running, not enrolling
- Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed
- ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System — Running, not enrolling
- A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) — Completed
- A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD) — Completed
- Study to Evaluate Tezepelumab in Adults With Chronic Spontaneous Urticaria — Completed
- A Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma — Completed
- Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer — Completed
- A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome — Completed
- Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3 — Completed
- Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients — Completed